Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry

BACKGROUND: Previous studies examining the use of direct oral anticoagulants (DOACs) in atrial fibrillation (AF) have largely focused on patients newly initiating therapy. Little is known about the prevalence/patterns of switching to DOACs among AF patients initially treated with warfarin. HYPOTHESI...

Descripción completa

Detalles Bibliográficos
Autores principales: Sciria, Christopher T., Maddox, Thomas M., Marzec, Lucas, Rodwin, Benjamin, Virani, Salim S., Annapureddy, Amarnath, Freeman, James V., O'Hare, Ali, Liu, Yuyin, Song, Yang, Doros, Gheorghe, Zheng, Yue, Lee, Jane J., Daggubati, Ramesh, Vadlamani, Lina, Cannon, Christopher, Desai, Nihar R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368350/
https://www.ncbi.nlm.nih.gov/pubmed/32378265
http://dx.doi.org/10.1002/clc.23376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368350/
https://www.ncbi.nlm.nih.gov/pubmed/32378265
http://dx.doi.org/10.1002/clc.23376

Ejemplares similares